Citigroup’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
-$1 5866
2024
Q4
Sell
-7
Closed -$104 5811
2024
Q3
$132 Sell
7
-109
-94% -$2.85K ﹤0.01% 5527
2024
Q2
$2.62K Sell
116
-22
-16% -$657 ﹤0.01% 5315
2024
Q1
$7.11K Buy
138
+21
+18% +$1.17K ﹤0.01% 5271
2023
Q4
$8.28K Buy
117
+115
+5,750% +$7.93K ﹤0.01% 5237
2023
Q3
$172 Sell
2
-488
-100% -$50.7K ﹤0.01% 5339
2023
Q2
$73.3K Buy
+490
New +$67.7K ﹤0.01% 4404
2023
Q1
Sell
-9
Closed -$872 5775
2022
Q4
$872 Buy
9
+2
+29% +$433 ﹤0.01% 5421
2022
Q3
$2K Sell
7
-25
-78% -$6.25K ﹤0.01% 5519
2022
Q2
$6K Buy
+32
New +$8.91K ﹤0.01% 5560

Other funds holding PIII

Citigroup's PIII Position: Q1 2025 in Review

Citigroup held its P3 Health Partners (PIII) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5866.

Citigroup first reported a position in PIII in Q2 2022 and has held it in 9 quarters since. The position peaked at $73.3K in Q2 2023. 33 funds tracked by Wall St. Rank hold PIII as of Q1 2025.

  • Citigroup held 0 shares of P3 Health Partners worth $0 as of Q1 2025.
  • Citigroup left its P3 Health Partners share count unchanged in Q1 2025.
  • P3 Health Partners made up ﹤0.01% of Citigroup's portfolio in Q1 2025, its #5866 holding.
  • Citigroup first reported a position in P3 Health Partners in Q2 2022 and has held it in 9 quarters since.
  • Citigroup's P3 Health Partners position peaked at $73.3K in Q2 2023.
  • 33 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.